Trial Profile

YY-20394 Combined With GEMOX in the Treatment of Patients With Relapsed and/or Refractory Diffuse Large B-cell Lymphoma With a Single Arm, Open, Multicentrized Phase 1b/2 Clinical Trial

Status: Recruiting

Phase of Trial: Phase I/II

Latest Information Update: 19 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Dec 2023 Results(Between September 2020 and June 2021, n=39 patients) presented at the 65th American Society of Hematology Annual Meeting and Exposition
15 Jun 2023 Results (n=39; as of 11 Oct 2021) of a post-hoc analysis using data from this trial and assessing association between different subtypes and clinical response to combined treatment presented at the 28th Congress of the European Haematology Association
14 Dec 2021 Status changed to recruiting, as per results presented at the 63rd American Society of Hematology Annual Meeting and Exposition.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com